Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇩🇪DE · Daily News#1305K to 30K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
1.5K to 9K🎙 Daily cadence·315 episodes·Last published 1w ago - Monthly Reach
Unique listeners across all episodes (30 days)
5K to 30K🇩🇪100% - Active Followers
Loyal subscribers who consistently listen
2K to 12K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 21 epsHost
Recent guests
No guests detected in recent episodes.
Recent episodes
Johnson and Johnson Stock Holds Steady on Strong Earnings and Analyst Support
Jun 13, 2026
3m 12s
Johnson and Johnson Sees Modest Trading Strength as Oncology Strategy Gains Focus
Jun 12, 2026
2m 38s
Johnson and Johnson Gains Momentum on Strong Earnings and Analyst Upgrades
Jun 11, 2026
2m 33s
J&J Stock Trading Above Key Averages as Healthcare Momentum Builds
Jun 10, 2026
1m 58s
Johnson and Johnson Holds Steady With Oncology Expansion Push
Jun 9, 2026
2m 29s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/13/26 | Johnson and Johnson Stock Holds Steady on Strong Earnings and Analyst Support✨ | stock analysisearnings report+4 | — | Johnson & JohnsonNYSE+3 | healthcare | Johnson & Johnson stockJNJ stock analysis+6 | — | 3m 12s | |
| 6/12/26 | Johnson and Johnson Sees Modest Trading Strength as Oncology Strategy Gains Focus✨ | stock analysisoncology strategy+4 | — | JNJJohnson & Johnson+3 | — | Johnson & Johnson stockJNJ analysis+6 | — | 2m 38s | |
| 6/11/26 | Johnson and Johnson Gains Momentum on Strong Earnings and Analyst Upgrades✨ | stock performanceearnings analysis+4 | — | JNJJohnson & Johnson+1 | NYSE | Johnson & JohnsonJNJ+5 | — | 2m 33s | |
| 6/10/26 | J&J Stock Trading Above Key Averages as Healthcare Momentum Builds✨ | stock analysishealthcare sector+3 | — | JNJJohnson & Johnson+1 | — | Johnson & JohnsonJNJ stock+5 | — | 1m 58s | |
| 6/9/26 | Johnson and Johnson Holds Steady With Oncology Expansion Push✨ | stock analysisoncology expansion+3 | — | Johnson & JohnsonFirefly Bio+1 | — | Johnson & Johnson stockJNJ stock analysis+5 | — | 2m 29s | |
| 6/6/26 | Johnson and Johnson: Steady Growth Facing Patent Headwinds✨ | stock analysispharmaceutical industry+4 | — | StelaraJohnson & Johnson+2 | China | Johnson & JohnsonJNJ stock+7 | — | 2m 42s | |
| 6/5/26 | Johnson and Johnson Stock Approaches Upper Range: A Defensive Healthcare Leader Worth Watching✨ | stock analysishealthcare stocks+4 | — | JNJJohnson & Johnson+4 | — | Johnson & Johnson stockJNJ stock analysis+6 | — | 3m 42s | |
| 6/4/26 | Johnson and Johnson Stock: Defensive Blue Chip Stability in Uncertain Markets✨ | stock analysishealthcare+4 | — | Johnson & JohnsonKenvue+12 | — | Johnson & JohnsonJNJ stock+6 | — | 3m 12s | |
| 6/3/26 | Johnson and Johnson Stock Pullback: Defensive Healthcare Play Amid Legal Headwinds✨ | stock analysishealthcare investment+4 | — | Johnson & JohnsonNYSE+7 | — | Johnson & Johnsonstock performance+6 | — | 3m 43s | |
| 5/21/26 | JNJ Stock Update: Trading in Mid-200s with Mixed Analyst Outlook and Legal Headwinds✨ | stock analysistrading metrics+4 | — | JNJJohnson & Johnson+3 | — | JNJ stocktrading volume+5 | — | 2m 53s | |
| 5/5/26 | Johnson and Johnson Stock Down 8 Percent Since February: What's Behind the Decline?✨ | stock analysismarket update+3 | — | JNJJohnson & Johnson+1 | — | Johnson & Johnson stockJNJ stock analysis+3 | — | 2m 18s | |
| 5/2/26 | Johnson and Johnson Stock Surges on Strong Earnings and Raised Guidance✨ | stock analysisearnings report+3 | — | JNJJohnson & Johnson+2 | — | Johnson & Johnson stockJNJ stock analysis+3 | — | 2m 37s | |
| 5/1/26 | JNJ Holds Steady at $229.85: Healthcare Giant Shows Modest Gains✨ | stock analysismarket update+3 | — | JNJJohnson & Johnson+1 | — | Johnson & Johnson stockJNJ stock analysis+5 | — | 2m 19s | |
| 4/30/26 | JNJ Stock Slides Amid Low Volume: What's Behind Johnson and Johnson's Recent Decline?✨ | stock performance analysistrading volume trends+3 | — | JNJJohnson & Johnson | — | Johnson & Johnson stockJNJ analysis+6 | — | 2m 19s | |
| 4/29/26 | JNJ Rallies: Johnson and Johnson Stock Climbs to 227.79 Amid Steady Healthcare Performance✨ | stock performancehealthcare sector+3 | — | JNJJohnson & Johnson | — | Johnson & Johnson stockJNJ stock analysis+5 | — | 2m 15s | |
| 4/28/26 | JNJ Stock Slides in April: What Healthcare Investors Need to Know✨ | stock analysishealthcare investments+4 | — | JNJJohnson & Johnson+3 | — | Johnson & Johnson stockJNJ stock price+6 | — | 2m 14s | |
| 4/25/26 | JNJ Stock Slides to 228 Dollars Amid Light Trading Volume in Late April✨ | stock analysistrading performance+4 | — | JNJ stockJohnson & Johnson | — | Johnson & Johnson stockJNJ stock+5 | — | 2m 12s | |
| 4/24/26 | JNJ Shows Resilience with Modest Gains Amid Market Volatility✨ | stock analysismarket volatility+3 | — | JNJJohnson & Johnson | — | Johnson & Johnson stockJNJ stock analysis+3 | — | 2m 35s | |
| 4/23/26 | JNJ Holds Steady: Defensive Gains and Medical Innovation Drive Long-Term Appeal✨ | stock analysismarket performance+3 | — | CARTO-Powered technologyJNJ stock+2 | — | Johnson & JohnsonJNJ stock+5 | — | 2m 23s | |
| 4/22/26 | Johnson and Johnson Stock Faces Modest Decline Amid April Volatility✨ | stock performancemarket analysis+4 | — | J&J stockblue-chip healthcare stocks+4 | America | Johnson & JohnsonJ&J stock+6 | — | 2m 32s | |
| 4/21/26 | JNJ Raises Guidance: Pharma Giant Shows Resilience Despite Today's Decline✨ | stock analysismarket update+3 | — | JNJJohnson & Johnson+1 | — | Johnson & JohnsonJNJ stock+3 | — | 2m 09s |
Showing 21 of 21
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.